Patents by Inventor Patricia Murphy
Patricia Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210093575Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.Type: ApplicationFiled: October 9, 2020Publication date: April 1, 2021Inventors: Andrea ROURKE, Maura Patricia MURPHY, James Frederick PFEIFFER, Clark Patrick ALLPHIN, Alya Khan McGINLAY
-
Publication number: 20180316145Abstract: A device, system, and method for connecting a peripheral device to a power source. The device may include a housing including a first portion coupled to a second portion, the first portion including a face portion and an edging portion, the edging portion edging portion defining the housing thickness. The housing may have an internal chamber, within which may be a circuitry component, at least a portion of at least one plug component, at least one connection port in the housing edging portion, and a light source within the housing interior chamber. Further, each connection port may have a connection port cover that is configured to selectively obstruct or unobstruct the connection port by the application of a minimum amount of activation force against the connection port cover.Type: ApplicationFiled: April 28, 2017Publication date: November 1, 2018Inventors: Glenn C. MCKIERNAN, Robert J. BLAIR, Patricia MURPHY
-
Publication number: 20180250557Abstract: A system and device system for controlling a height of a levitated object based on a height selection made by a user. The system includes a user input device configured to receive the height selection made by the user, a base in communication with the user input device, and a power source. The base includes a magnet array having a central electromagnet configured to exert an adjustable magnetic force in a first direction, a plurality of peripheral electromagnets each being configured to exert an adjustable magnetic force in the first direction, and a permanent magnet being configured to exert a non-adjustable magnet force in a second direction at least substantially opposite the first direction. The power source is configured to deliver an adjustable current to the magnet array, such that adjustment of the current controls the levitation height of the object.Type: ApplicationFiled: March 2, 2017Publication date: September 6, 2018Inventors: Glenn MCKIERNAN, Robert J BLAIR, Patricia MURPHY
-
Patent number: 10065081Abstract: A system and device system for controlling a height of a levitated object based on a height selection made by a user. The system includes a user input device configured to receive the height selection made by the user, a base in communication with the user input device, and a power source. The base includes a magnet array having a central electromagnet configured to exert an adjustable magnetic force in a first direction, a plurality of peripheral electromagnets each being configured to exert an adjustable magnetic force in the first direction, and a permanent magnet being configured to exert a non-adjustable magnet force in a second direction at least substantially opposite the first direction. The power source is configured to deliver an adjustable current to the magnet array, such that adjustment of the current controls the levitation height of the object.Type: GrantFiled: March 2, 2017Date of Patent: September 4, 2018Assignee: GTB Innovations, LLCInventors: Glenn McKiernan, Robert J Blair, Patricia Murphy
-
Publication number: 20180042855Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.Type: ApplicationFiled: October 23, 2017Publication date: February 15, 2018Inventors: Andrea Marie ROURKE, Maura Patricia MURPHY, James Frederick PFEIFFER, Clark Patrick ALLPHIN, Alya Kahn MCGINLAY
-
Patent number: 9795567Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.Type: GrantFiled: June 3, 2014Date of Patent: October 24, 2017Assignee: JAZZ PHARMACEUTICALS, INC.Inventors: Andrea Marie Rourke, Maura Patricia Murphy, James Frederick Pfeiffer, Clark Patrick Allphin, Alya Kahn McGinlay
-
Publication number: 20160078745Abstract: A proximity sensor system configured to allow a user to identify a lost or misplaced item. The proximity sensor system includes a base unit and at least one remote unit that is disposed on a user's personal possession. The base unit includes a receiving assembly having a proximity sensor having a receiver, and each remote unit includes a transmitting assembly having a proximity sensor having a transmitter. The receiver and the transmitter are in continuous wireless communication within a set effective range. If the receiver and the transmitter exceed the set effective range, each proximity sensor is configured to transmit a signal to a microprocessor to emit an audible alert. Each remote unit has a unique audible alert, thereby allowing the user to quickly identify the specific personal possession that is lost.Type: ApplicationFiled: August 28, 2015Publication date: March 17, 2016Inventor: Patricia Murphy
-
Publication number: 20140348917Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.Type: ApplicationFiled: June 3, 2014Publication date: November 27, 2014Applicant: Jazz Pharmaceuticals, Inc.Inventors: Andrea Marie Rourke, Maura Patricia Murphy, James Frederick Pfeiffer, Clark Patrick Allphin, Alya Kahn McGinlay
-
Patent number: 8778398Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.Type: GrantFiled: May 4, 2010Date of Patent: July 15, 2014Assignee: Jazz Pharmaceuticals, Inc.Inventors: Andrea Marie Rourke, Maura Patricia Murphy, James Frederick Pfeiffer, Clark Patrick Allphin, Alya Khan McGinlay
-
Publication number: 20130031717Abstract: The system of the present application is directed towards a shower liner system including a plurality of layers, each of the plurality of layers including a top portion, the top portion of each of the plurality of layers having a plurality of attachment points, a bottom portion and a line of perforation separating the top portion and the bottom portion, wherein a bottom portion of each of the plurality of layers can be removed without removing the top portion, and wherein the upper portion of each of the plurality of layers are fastened together. The method of the present application is directed towards a method of using a shower liner system.Type: ApplicationFiled: June 27, 2012Publication date: February 7, 2013Inventors: Denise Roland, Patricia Murphy, Janice Roland, Vincent Vaccaro
-
Patent number: 8139078Abstract: In accordance with one embodiment, a method for emulating the color performance of a display system includes determining an expected first color gamut of the display system. Display data is converted into a format that emulates the first color gamut. The converted display data is displayed by a different display system having an expected second color gamut different than the expected first color gamut.Type: GrantFiled: April 10, 2008Date of Patent: March 20, 2012Assignee: Texas Instruments IncorporatedInventors: Erin Patricia Murphy Smoyer, Gregory S. Pettitt, Jason Ryan Thompson
-
Publication number: 20110111027Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.Type: ApplicationFiled: May 4, 2010Publication date: May 12, 2011Applicant: JAZZ PHARMACEUTICALS, INC.Inventors: ANDREA MARIE ROURKE, MAURA PATRICIA MURPHY, JAMES FREDERICK PFEIFFER, CLARK PATRICK ALLPHIN, ALYA KHAN MCGINLAY
-
Publication number: 20090256856Abstract: In accordance with one embodiment, a method for emulating the color performance of a display system includes determining an expected first color gamut of the display system. Display data is converted into a format that emulates the first color gamut. The converted display data is displayed by a different display system having an expected second color gamut different than the expected first color gamut.Type: ApplicationFiled: April 10, 2008Publication date: October 15, 2009Applicant: Texas Intruments IncorporatedInventors: Erin Patricia Murphy Smoyer, Gregory S. Pettitt, Jason Ryan Thompson
-
Patent number: 7265794Abstract: Providing color management includes receiving measurements of the intensity of colors. A light source generates light beams to yield the colors, where the light beams are generated in accordance to image data to create an image. A target color value is established. A duty cycle sequence operable to control the light source is selected in accordance with the measurements and the target color value. Current levels for currents provided to the light source are selected in accordance with the duty cycle sequence and the target color value.Type: GrantFiled: September 1, 2005Date of Patent: September 4, 2007Assignee: Texas Instruments IncorporatedInventors: Harold E. Bellis, II, Erin Patricia Murphy Smoyer, Nguyen Trong Ho
-
Publication number: 20070038298Abstract: The present invention provides a method of repairing a tympanic membrane deformity, such as a tympanic membrane perforation, commonly referred to as tympanoplasty or myringoplasty, using a collagen biofabric. The collagen biofabric is preferably laminated. The invention further provides kits comprising one or more pieces of collagen biofabric, for example laminated collagen biofabric, for the repair of a tympanic membrane.Type: ApplicationFiled: June 29, 2006Publication date: February 15, 2007Inventors: Joseph Sulner, Janice Smiell, Sharon Bourke, Patricia Murphy
-
Publication number: 20060154272Abstract: Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.Type: ApplicationFiled: November 7, 2005Publication date: July 13, 2006Inventors: Patricia Murphy, Marga White, Mark Rabin, Sheri Olson, Matthew Yoshikawa, Geoffrey Jackson, Tara Eskandari, Brenda Schryer, Michael Park
-
Publication number: 20040048796Abstract: The present invention relates to collagenous membranes produced from amnion, herein referred to as a collagen biofabric. The collagen biofabric of the invention has the structural integrity of the native non-treated amniotic membrane, i.e., the native tertiary and quaternary structure. The present invention provides a method for preparing a collagen biofabric from a placental membrane, preferably a human placental membrane having a chorionic and amniotic membrane, by decellularizing the amniotic membrane. In a preferred embodiment, the amniotic membrane is completely decellularized. The collagen biofabric of the invention has numerous utilities in the medical and surgical field including for example, blood vessel repair, construction and replacement of a blood vessel, tendon and ligament replacement, wound-dressing, surgical grafts, ophthalmic uses, sutures, and others.Type: ApplicationFiled: March 26, 2003Publication date: March 11, 2004Inventors: Robert J. Hariri, Aleksandr M. Kaplunovsky, Patricia A. Murphy
-
Publication number: 20030187515Abstract: A method of preparing a placental-derived amniotic membrane biofabric is provided. The biofabric is a dry decellularized amniotic membrane that is capable of being stored at room temperature, and subsequent to rehydration can be used for a variety of medical and/or research purposes. A laminate of said biofabric is also provided that can be shaped into complex shapes and repopulated with cells to generate both acellular and cellularized engineered tissues and organoids.Type: ApplicationFiled: March 26, 2002Publication date: October 2, 2003Inventors: Robert J. Hariri, Aleksandr M. Kaplunovsky, Patricia A. Murphy
-
Patent number: 5707269Abstract: A child's toy which includes a plurality of detachable planar wall members. Each of the wall members has an exterior surface, an interior surface, and a plurality of side edges. The side edges define four corners. A plurality of VELCRO hook and loop type fastening strips are secured to each of the wall members. Each of the hook and loop type fastening strips on the wall members is adapted to mate with a complementary loop and hook type fastening strip on a different wall member in order to secure the wall members together. The child's toy includes at least one three dimensional toy figure releasably fastened to the interior surface of one of the wall members.Type: GrantFiled: May 17, 1996Date of Patent: January 13, 1998Inventor: Patricia Murphy